vimarsana.com

Page 324 - சந்தைப்படுத்தல் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sigma Pensions urges youths to set retirement goals

Punch Newspapers Sections Nike Popoola Sigma Pensions has urged youths to start early financial future plans by setting their retirement goals and vigilantly saving towards it. In a statement titled ‘Sigma Pensions harps on setting retirements goals among youths’, it said this was part of its responsible practice of continually supporting youths through its various financial literacy initiatives. The Head Risk Management, Sigma Pensions, Ms Paula Benedict, said this during a collaborative webinar organised by Sigma Pensions and Junior Achievement Nigeria youth webinar, which had over 100 youths in attendance. The statement said the webinar was a financial literacy initiative for youths themed ‘Break free’, which also featured the Founder of Twelve Vest, Mrs Tomie Balogun; and the Head, Business Development, Piggyvest, Mr Ayo Akinola, who spoke on the opportunities in the country, goal setting, savings and adopting technology to aid savings.

Parking Compliance Coordinator (Regina, CA)

Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio

Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body s own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role because they use standard inbred mice that have a competent immune system, which is required to evaluate immune-modulating therapies. These models are engrafted with mouse tumors derived from the same strain background; this genetic similarity between tumor and host prevents the host from rejecting the tumor.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.